Barrett Esophagus: Perspectives on Its Diagnosis and Management in Asian Populations

Overview

Journal Gastroenterol Hepatol (N Y)

Specialty Gastroenterology

Date 2012 Jul 17

PMID 22798736

Citations 13

Authors

Yuji Amano

Yoshikazu Kinoshita

Affiliations

Soon will be listed here.

Abstract

Barrett esophageal cancer has the fastest growing incidence of any cancer in Western countries. In Asian countries, most cases of esophageal cancer consist of squamous cell carcinomas, not adenocarcinomas. Recently, however, the increase in the number of Barrett esophagus cases with subsequent Barrett cancer has become worrisome in Asian countries, as the number of patients with gastro-esophageal reflux disease has been increasing in these countries. In this review, recent reports regarding Barrett esophagus in Asian countries have been collected and this problem is discussed from various perspectives. In Asia, long-segment Barrett esophagus is much less prevalent than in Western countries, whereas short-segment Barrett esophagus is frequently found. In epidemiologic studies, evaluation of the prevalence of Barrett esophagus is limited by poor interob-server diagnostic agreement. Standard criteria for the endoscopic diagnosis of Barrett esophagus in Asian patients, especially of the short-segment type, should be established as soon as possible. A high prevalence of hiatal hernia and a decreasing prevalence of Helico-bacter pylori infection may increase the number of Barrett esophagus cases and subsequent Barrett cancer in Asian countries in the near future. Therefore, a strategy for the clinical management of Barrett esophagus in Asian countries should be devised.

Citing Articles

Clinicopathological Characteristics of Superficial Barrett's Adenocarcinoma in a Japanese Population: A Retrospective, Multicenter Study.

Hamada K, Kanzaki H, Miyahara K, Nakagawa M, Mouri H, Mizuno M Intern Med. 2022; 61(8):1115-1123.

PMID: 35431302 PMC: 9107981. DOI: 10.2169/internalmedicine.6942-20.

Prevalence of Barrett's Epithelium Shown by Endoscopic Observations with Linked Color Imaging in Subjects with Different H. pylori Infection Statuses.

Adachi K, Ishimura N, Kishi K, Notsu T, Mishiro T, Sota K Intern Med. 2020; 60(5):667-674.

PMID: 32999237 PMC: 7990643. DOI: 10.2169/internalmedicine.5676-20.

Barretts's carcinogenesis.

Mukaisho K, Kanai S, Kushima R, Nakayama T, Hattori T, Sugihara H Pathol Int. 2019; 69(6):319-330.

PMID: 31290583 PMC: 6851828. DOI: 10.1111/pin.12804.

Relationship between Barrett's esophagus and colonic diseases: a role for colonoscopy in Barrett's surveillance.

Amano Y, Nakahara R, Yuki T, Murakami D, Ujihara T, Tomoyuki I J Gastroenterol. 2019; 54(11):984-993.

PMID: 31240437 DOI: 10.1007/s00535-019-01600-x.

Circular stripes were more common in Barrett's esophagus after acetic acid staining.

Sun Y, Ma S, Fang L, Wang J, Dong L BMC Gastroenterol. 2018; 18(1):17.

PMID: 29370762 PMC: 5784670. DOI: 10.1186/s12876-018-0745-7.

References

Amano Y, Ishimura N, Furuta K, Takahashi Y, Chinuki D, Mishima Y . Which landmark results in a more consistent diagnosis of Barrett's esophagus, the gastric folds or the palisade vessels?. Gastrointest Endosc. 2006; 64(2):206-11. DOI: 10.1016/j.gie.2006.04.029. View

Loffeld R, van der Putten A . Helicobacter pylori and gastro-oesophageal reflux disease: a cross-sectional epidemiological study. Neth J Med. 2004; 62(6):188-91. View

Yuki T, Amano Y, Kushiyama Y, Takahashi Y, Ose T, Moriyama I . Evaluation of modified crystal violet chromoendoscopy procedure using new mucosal pit pattern classification for detection of Barrett's dysplastic lesions. Dig Liver Dis. 2006; 38(5):296-300. DOI: 10.1016/j.dld.2006.01.028. View

Anderson L, Johnston B, Watson R, Murphy S, Ferguson H, Comber H . Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Cancer Res. 2006; 66(9):4975-82. DOI: 10.1158/0008-5472.CAN-05-4253. View

Hirota W, Loughney T, Lazas D, Maydonovitch C, Rholl V, Wong R . Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology. 1999; 116(2):277-85. DOI: 10.1016/s0016-5085(99)70123-x. View

Noda T . Angioarchitectural study of esophageal varices. With special reference to variceal rupture. Virchows Arch A Pathol Anat Histopathol. 1984; 404(4):381-92. DOI: 10.1007/BF00695222. View

Rajendra S, Ackroyd R, Robertson I, Ho J, Karim N, Kutty K . Helicobacter pylori, ethnicity, and the gastroesophageal reflux disease spectrum: a study from the East. Helicobacter. 2007; 12(2):177-83. DOI: 10.1111/j.1523-5378.2007.00489.x. View

Rosaida M, Goh K . Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study. Eur J Gastroenterol Hepatol. 2004; 16(5):495-501. DOI: 10.1097/00042737-200405000-00010. View

Guillem P, Billeret V, Buisine M, Flejou J, Lecomte-Houcke M, Degand P . Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus. Int J Cancer. 2000; 88(6):856-61. DOI: 10.1002/1097-0215(20001215)88:6<856::aid-ijc3>3.0.co;2-d. View

10.

Takubo K, Nixon J, Jass J . Ducts of esophageal glands proper and paneth cells in Barrett's esophagus: frequency in biopsy specimens. Pathology. 1995; 27(4):315-7. DOI: 10.1080/00313029500169213. View

11.

Wani S, Sampliner R, Weston A, Mathur S, Hall M, Higbee A . Lack of predictors of normalization of oesophageal acid exposure in Barrett's oesophagus. Aliment Pharmacol Ther. 2005; 22(7):627-33. DOI: 10.1111/j.1365-2036.2005.02626.x. View

12.

Vieth M, Masoud B, Meining A, Stolte M . Helicobacter pylori infection: protection against Barrett's mucosa and neoplasia?. Digestion. 2000; 62(4):225-31. DOI: 10.1159/000007820. View

13.

Wong W, Lam S, Hui W, Lai K, Chan C, Hu W . Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese--prevalence and spectrum of the disease. Aliment Pharmacol Ther. 2002; 16(12):2037-42. DOI: 10.1046/j.1365-2036.2002.01373.x. View

14.

Takubo K, Vieth M, Aryal G, Honma N, Sawabe M, Arai T . Islands of squamous epithelium and their surrounding mucosa in columnar-lined esophagus: a pathognomonic feature of Barrett's esophagus?. Hum Pathol. 2005; 36(3):269-74. DOI: 10.1016/j.humpath.2005.01.012. View

15.

Rajendra S, Kutty K, Karim N . Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all. Dig Dis Sci. 2004; 49(2):237-42. DOI: 10.1023/b:ddas.0000017444.30792.94. View

16.

Amano Y, Ishihara S, Kushiyama Y, Yuki T, Takahashi Y, Chinuki D . Barrett's oesophagus with predominant intestinal metaplasia correlates with superficial cyclo-oxygenase-2 expression, increased proliferation and reduced apoptosis: changes that are partially reversed by non-steroidal anti-inflammatory drugs usage. Aliment Pharmacol Ther. 2004; 20(7):793-802. DOI: 10.1111/j.1365-2036.2004.02195.x. View

17.

Amano Y, Kushiyama Y, Yuki T, Takahashi Y, Chinuki D, Ishimura N . Predictors for squamous re-epithelialization of Barrett's esophagus after endoscopic biopsy. J Gastroenterol Hepatol. 2007; 22(6):901-7. DOI: 10.1111/j.1440-1746.2006.04369.x. View

18.

Kim J, Rhee P, Lee J, Lee H, Choi Y, Son H . Prevalence and risk factors of Barrett's esophagus in Korea. J Gastroenterol Hepatol. 2007; 22(6):908-12. DOI: 10.1111/j.1440-1746.2006.04448.x. View

19.

Choi D, Oh S, Baek S, Ahn S, Chang Y, Jeong W . Endoscopically observed lower esophageal capillary patterns. Korean J Intern Med. 2003; 17(4):245-8. PMC: 4531684. DOI: 10.3904/kjim.2002.17.4.245. View

20.

Guelrud M, Herrera I, Essenfeld H, Castro J . Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc. 2001; 53(6):559-65. DOI: 10.1067/mge.2001.114059. View